Ladenburg Thalmann Financial Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Sell	4 -1	-20%	-$182	﹤0.01%	5260
2019 Q3	$0	Hold	5	–	–	﹤0.01%	5512
2019 Q2	$0	Hold	5	–	–	﹤0.01%	5464
2019 Q1	$0	Buy	+5	New	+$415	﹤0.01%	5389

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RETA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) stake by 20% in Q4 2019, selling an estimated $182 and leaving 4 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5260.

Ladenburg Thalmann Financial Services first reported a position in RETA in Q1 2019 and has held it in 4 quarters since. 218 funds tracked by Wall St. Rank hold RETA as of Q4 2019.

Ladenburg Thalmann Financial Services held 4 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $1K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 1 Reata Pharmaceuticals, Inc. Class A Common Stock share in Q4 2019, an estimated $182.
Reata Pharmaceuticals, Inc. Class A Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5260 holding.
Ladenburg Thalmann Financial Services first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2019 and has held it in 4 quarters since.
218 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.